Item Posts Archive - Page 25 of 1770 - Medivizor
Navigation Menu

Evaluating the effectiveness of chemotherapy before surgery for patients with colorectal cancer liver metastases.

Evaluating the effectiveness of chemotherapy before surgery for patients with colorectal cancer liver metastases.

Posted by on Mar 5, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness of chemotherapy given before surgery (neoadjuvant chemotherapy; NAC) for the treatment of patients with colorectal cancer liver metastasis (CRLM) at high risk. The data showed that NAC improved the overall survival of these patients. Some background Colorectal cancer (CRC) is one of the most common...

Read More

Benefits of combination treatment for diabetic peripheral neuropathic pain.

Benefits of combination treatment for diabetic peripheral neuropathic pain.

Posted by on Mar 5, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effectiveness and safety of combinations of anti-depressive medication for the treatment of diabetic peripheral neuropathic pain (DPNP) in patients with diabetes. The study showed that combination treatment improved pain in these patients and was well tolerated.  Some background DPNP occurs in patients...

Read More

Reviewing the significance of very low carbohydrate diets in type 2 diabetes.

Reviewing the significance of very low carbohydrate diets in type 2 diabetes.

Posted by on Mar 5, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effect of very low carbohydrate (VLC) or ketogenic diets (KDs) with higher carbohydrate diets in patients with pre-diabetes or type 2 diabetes (T2D). The data showed that reduced levels of glycated hemoglobin (HbA1c) and triglycerides may occur with VLC or KDs, but with limited advantages over other diets. Some...

Read More

Combining a “herbal” and conventional disease-modifying anti-rheumatic drug for treating rheumatoid arthritis.

Combining a “herbal” and conventional disease-modifying anti-rheumatic drug for treating rheumatoid arthritis.

Posted by on Mar 5, 2023 in Rheumatoid Arthritis | 0 comments

In a nutshell This study explored the effectiveness and safety of tripterygium glycosides (TG) as a disease-modifying anti-rheumatic drug (DMARD) when combined with conventional DMARDs for treating rheumatoid arthritis (RA). The authors concluded that good safety and better improvements in RA symptoms were observed when TG was combined with a...

Read More

Can once-weekly administered semaglutide reduce adipose tissue and fat in patients with type 2 diabetes?

Can once-weekly administered semaglutide reduce adipose tissue and fat in patients with type 2 diabetes?

Posted by on Mar 5, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effect of subcutaneous semaglutide (Ozempic) on body composition in patients with type 2 diabetes (T2D). The data showed significant weight loss in these patients after 3 months of semaglutide treatment based on reduced visceral adipose tissue (VAT) thickness and fat mass (FM). Some background T2D is...

Read More